C. Grunert

Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires

D. Beule, G. Willimsky, T. Blankenstein, 2022, Cancers.

Long‐term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges

B. Obermayer, L. Bullinger, D. Beule, 2021, International journal of cancer.

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

S. Haas, C. Weidinger, M. Wirth, 2022, The Journal of clinical investigation.

High-affinityT-cellreceptorspecificfor MyD88L265Pmutationforadoptive T-celltherapyofB-cellmalignancies

P. Kloetzel, U. Keller, A. Pezzutto, 2021 .

Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial.

P. Fasching, T. Fehm, A. Schneeweiss, 2021, European journal of cancer.

High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies

P. Kloetzel, U. Keller, A. Pezzutto, 2021, Journal for ImmunoTherapy of Cancer.